Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 8/20 | 1.00 |
| ▸ | CNR1 | P21554 | 2/20 | 1.00 |
| ▸ | CNR2 | P34972 | 2/20 | 1.00 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 1.00 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 1.00 |
| ▸ | TRPA1 | O75762 | 1/20 | 1.00 |
| ▸ | INHA | P05111 | 1/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 1/20 | 1.00 |
| ▸ | HTR2A | P28223 | 1/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 1/20 | 1.00 |
| ▸ | OPRM1 | P35372 | 1/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 1/20 | 1.00 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 1.00 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 1.00 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 1.00 |
| ▸ | TRPV2 | Q9Y5S1 | 1/20 | 1.00 |
| ▸ | TRPM7 | Q96QT4 | 1/20 | 0.63 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.63 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.62 |
| ▸ | BACE1 | P56817 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cannabigerol SCHEMBL12954626 | 1.00 | PPARG (1.00) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| Cannabigerol SCHEMBL144819 | 1.00 | PPARG (1.00) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23522969 | 0.99 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23523643 | 0.99 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23523493 | 0.99 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23523543 | 0.99 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23523642 | 0.99 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23523492 | 0.99 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23523454 | 0.99 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23523040 | 0.99 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12161608-B2 | Methods of preventing and treating health conditions using cannabinoid anions | Natural Extraction Systems, LLC (US) | 2024-12-10 | — | — | US | claimed |
| US-20220401382-A1 | METHODS OF PREVENTING AND TREATING HEALTH CONDITIONS USING CANNABINOID ANIONS | Natural Extraction Systems, LLC (US) | 2022-12-22 | — | — | US | claimed |
| WO-2021127559-A1 | COMPOSITIONS COMPRISING CANNABINOID ANIONS AND ANTI-NUCLEATING AGENTS | Natural Extraction Systems, LLC (US) | 2021-06-24 | — | — | WO | claimed |
| WO-2021097163-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING CANNABINOID ANIONS | Natural Extraction Systems, LLC (US) | 2021-05-20 | — | — | WO | claimed |
| WO-2021097150-A1 | METHODS OF PREVENTING AND TREATING HEALTH CONDITIONS USING CANNABINOID ANIONS | Natural Extraction Systems, LLC (US) | 2021-05-20 | — | — | WO | claimed |
| WO-2021041637-A1 | COMPOSITIONS COMPRISING CANNABINOID IONS DISSOLVING IN GLYCEROL | Natural Extraction Systems, LLC (US) | 2021-03-04 | — | — | WO | claimed |
| US-20200367493-A1 | BIOCONTROL ENHANCERS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2020-11-26 | — | — | US | claimed |
| US-10807931-B2 | Synthesis of phytocannabinoids including a decarboxylation step | THE UNIVERSITY OF SYDNEY (AU) | 2020-10-20 | — | — | US | claimed |
| US-20200172459-A1 | SYNTHESIS OF PHYTOCANNABINOIDS INCLUDING A DECARBOXYLATION STEP | THE UNIVERSITY OF SYDNEY (AU) | 2020-06-04 | — | — | US | claimed |
| US-12617765-B2 | Cannabinoid derivatives | CANOPY GROWTH CORPORATION (CA) | 2026-05-05 | — | — | US | disclosed |
| US-20260083161-A1 | CONTAINERS THAT CONTAIN ANIONIC CANNABINOIDS | NATURAL EXTRACTION SYS LLC (US) | 2026-03-26 | — | — | US | disclosed |
| US-12582663-B2 | Compositions comprising decarboxylated cannabinoids | Natural Extraction Systems, LLC (US) | 2026-03-24 | — | — | US | disclosed |
| US-20260069618-A1 | CANNABINOID ACID ESTER COMPOSITIONS AND USES THEREOF | EPM GROUP INC (US) | 2026-03-12 | — | — | US | disclosed |
| EP-4065549-B1 | CANNABINOID DERIVATIVES | CANOPY GROWTH CORP (CA) | 2026-03-11 | — | — | EP | disclosed |
| US-20150361469-A1 | CHEMICAL ENGINEERING PROCESSES AND APPARATUS FOR THE SYNTHESIS OF COMPOUNDS | FULL SPECTRUM LABORATORIES LIMITED (IE) | 2015-12-17 | — | — | US | disclosed |
| US-20150038567-A1 | Cannabinoid Carboxylic Acids, Salts of Cannabinoid Carboxylic Acids, and the Production and Uses of Same | THE HEALTH CONCEPT GMBH (DE) | 2015-02-05 | — | — | US | disclosed |
| WO-2014134281-A1 | BIOSYNTHESIS OF CANNABINOIDS | FULL SPECTRUM LABORATORIES LIMITED (IE) | 2014-09-04 | — | — | WO | disclosed |
| EP-2760444-A1 | CANNABINOID CARBOXYLIC ACIDS, SALTS OF CANNABINOID CARBOXYLIC ACIDS, AND THE PRODUCTION AND USES OF SAME | The Health Concept GmbH (DE) | 2014-08-06 | — | — | EP | disclosed |
| WO-2013045115-A1 | CANNABINOID CARBOXYLIC ACIDS, SALTS OF CANNABINOID CARBOXYLIC ACIDS, AND THE PRODUCTION AND USES OF SAME | THE HEALTH CONCEPT GMBH (DE) | 2013-04-04 | — | — | WO | disclosed |
| WO-2013035114-A1 | TP53 GENETIC VARIANTS PREDICTIVE OF CANCER | DECODE GENETICS EHF (IS) | 2013-03-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260069618-A1 | CANNABINOID ACID ESTER COMPOSITIONS AND USES THEREOF | CNR2, CNR1, IL17A | PPARG 121/4885CNR1 2/4885CNR2 1/4885 |
| US-20200172459-A1 | SYNTHESIS OF PHYTOCANNABINOIDS INCLUDING A DECARBOXYLATION STEP | CNR2, CNR1, CCNB1 | PPARG 1757/4885CNR1 2/4885CNR2 1/4885 |
| US-12617765-B2 | Cannabinoid derivatives | CNR2, CNR1, GPR18 | PPARG 130/4885CNR1 2/4885CNR2 1/4885 |
| US-20260083161-A1 | CONTAINERS THAT CONTAIN ANIONIC CANNABINOIDS | CNR2, CNR1, OPRD1 | PPARG 966/4885CNR1 2/4885CNR2 1/4885 |
| US-12582663-B2 | Compositions comprising decarboxylated cannabinoids | GGPS1, PGGT1B, CNR2 | PPARG 537/4885CNR1 8/4885CNR2 3/4885 |
| US-20150038567-A1 | Cannabinoid Carboxylic Acids, Salts of Cannabinoid Carboxylic Acids, and the Production and Uses of Same | CNR1, CNR2, HRH4 | PPARG 593/4885CNR1 1/4885CNR2 2/4885 |
| US-10807931-B2 | Synthesis of phytocannabinoids including a decarboxylation step | CNR2, CNR1, CCNB1 | PPARG 1757/4885CNR1 2/4885CNR2 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.